Lactococcus lactis is used as a fermentation starter in dairy or fermented foods and is a generally recognized as safe microorganism. Recently, probiotic L. lactis strains were reported to possess potential antipathogenic activity and suggested as functional foods for humans or additive to animal feed [2, 5, 16] . Probiotics are used to improve the intestinal microbiota balance. The intestinal microbiota has been reported to play a fundamental role in maintaining immune homeostasis [4, 8] . Immunity describes the state of having sufficient biological defenses to avoid infection, disease, or other unwanted biological invasion. Innate immunity is the natural resistance that provides resistance through several physical, chemical, and cellular approaches. Subsequent general defenses include secretion of chemical signals (cytokines) and antimicrobial substances, fever, and phagocytic activity associated with inflammatory responses. Through these approaches, innate immunity can prevent the colonization of pathogenic bacteria and the proliferation of cancer cells.
Chronic inflammation that occurs in inflammatory bowel diseases (IBDs) induces persistent damage along the digestive tract and plays a role in the long-term development of colorectal cancer [6, 11] . Because of the involvement of inflammation in carcinogenesis, strategies to prevent many types of cancer, including colon cancer, focused on the use of nonsteroidal anti-inflammatory drugs [15] . Cytokineexpressing inflammatory cells produce large amounts of nitric oxide (NO), prostaglandin E 2 (PGE 2 ), and cytokines such as interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). NO and PGE 2 are important pro-inflammatory mediators produced by inducible NO synthase and cyclooxygenase-2 (COX-2), respectively [12] . The development of allergy has been explained through insufficient or aberrant exposure to environmental microbes. In the past, avoidance of allergens has been the standard treatment for allergies. However, induction of tolerance by exposure to antigens is an alternative to avoidance under the instructions of a doctor. Therefore, probiotics may be a safe alternative for providing the necessary microbial stimulation [13] .
Lactococcus lactis NK34 has been reported as a bacteriocin producer and probiotic strain that possesses antimicrobial activity, is tolerant to artificial gastric condition, reduces DNA damage, and is resistant to antibiotics [7] . However, L. lactis NK34 has not been studied for its anticancer effect against various cancer cells. Therefore, we investigated the 6 CFU/well of L. lactis NK34 resulted in strong inhibition of proliferation (>77% cytotoxicity, p < 0.05). The anti-inflammatory activity of L. lactis NK34 was also demonstrated in lipopolysaccharide-induced RAW 264.7 cells, where the production of nitric oxide and proinflammatory cytokines (tumor necrosis factor-α, interleukin-18, and cyclooxygenase-2) was reduced. These results suggest that L. lactis NK34 could be used as a probiotic microorganism to inhibit the proliferation of cancer cells and production of proinflammatory cytokines.
Keywords: Probiotic, Lactococcus lactis, anticancer activity, anti-inflammatory activity, cytokine anticancer effect against various cancer cells and antiinflammatory effect using NO and cytokine production. L. lactis NK34 was stored at -70°C in de Man, Rogosa, and Sharpe (MRS) broth (Difco Laboratories, Detroit, MI, USA) supplemented with 20% glycerol [7] . L. lactis NK34 was grown at 37°C on MRS agar plates. Before the experiments, overnight cultures were prepared in MRS broth. Cultures were harvested by centrifugation (10,000 ×g, 10 min); pellets were washed three times in phosphatebuffered saline (PBS) and then resuspended in PBS at a concentration of 10 7 colony forming units (CFU)/ml. and 1% streptomycin/penicillin (Gibco), at 37°C in an atmosphere of 5% CO 2 and 95% air.
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to evaluate the cytotoxicity of L. lactis NK34 [12] . Cells were plated at a density of 2 × 10 5 cells/well in a 96-well plate and cultured for 24 h. The culture medium was removed and the cell monolayers were washed twice with PBS. Then, 250 µl of culture medium and 10% FBS were added to each well. The wells were inoculated with 10 5 or 10 6 CFU/well of L. lactis NK34 and the plates were incubated at 37°C in an atmosphere of 5% CO 2 and 95% air. After 44 h, the supernatants were removed and the cells were washed once with PBS buffer. MTT solution (0.5 mg/ml) was added to the wells and the plates were incubated for 4 h. The purple MTT formazan crystals were dissolved by adding dimethyl sulfoxide to the wells. The absorbance was measured at 570 nm using an ELISA plate reader (Molecular Devices, Sunnyvale, CA, USA). The values were used to determine cell viability: Cytotoxicity = {1-[(absorbance of sample at 570 nm)/ (absorbance of control at 570 nm)]} × 100. The morphological effects of L. lactis NK34 were observed using a microscope (Olympus IX51 Clone; Olympus Melville, NY, USA). Cells were plated at a density of 1 × 10 5 cells/well in a 24-well plate and cultured for 24 h. The culture medium was removed and the cell monolayers were washed twice with PBS. Then, 1 ml of culture medium and 10% FBS were added to each well. The wells were inoculated with 10 6 CFU/well of L. lactis NK34 and the plate was inoculated at 37°C in an atmosphere of 5% CO 2 and 95% air. After 24 h, the supernatants were removed and the cells were washed once with PBS buffer. RAW 264.7 cells (1 × 10 6 cells/well) previously cultured in DMEM were stimulated for 24 h with lipopolysaccharide (LPS) (1 µg/ml) and L. lactis NK34 (10 5 and 10 6 cells/well) as previously described [8] . The NO concentration was determined by measuring the amount of nitrite in the cell culture supernatant using the Griess reagent. A 100 µl aliquot of the cell culture supernatant was mixed with 100 µl of Griess reagent and the mixture was incubated for 10 min at room temperature. The absorbance was measured at 540 nm using an ELISA plate reader (Molecular Devices), and the amount of NO was estimated from a calibration curve constructed using sodium nitrate as the standard. Total RNA was isolated from cell pellets using the EzWay total RNA isolation kit (Koma Biotech, Seoul, Korea). RT-PCRs were performed using a reverse transcription master premix (5×) (Elpis Biotech, Daejeon, Korea) on a Bioer XP Thermal Cycler (Bioer Technology, Hangzhou, China). One microliter of total RNA was reversed transcribed in a 20 µl reaction mixture containing PCR buffer, dNTP mix, primers, Taq DNA polymerase, cDNA, and nuclease-free water. Amplification was performed in a thermal cycler programmed as follows: pre-denaturation step (95°C, 15 min); 30 cycles of denaturation (95°C, 5 min), annealing (55-60°C, 1 min), and extension (72°C, 1 min); and a final extension step (72°C, 10 min).
RAW 264.7 cells were seeded at a density of 2 × 10 5 cells/well in 96-well culture plates and incubated for 24 h at 37°C in an atmosphere of 5% CO 2 and 95% air. The cells were activated by addition of 10 6 CFU/well of L. lactis NK34.
After 24 h of incubation, the supernatants were collected. The levels of TNF-α in the supernatants were determined using commercial ELISA kits (Koma Biotech). The production of TNF-α was demonstrated after the steps of coating antibody, blocking, treatment of each sample or standard, detection antibody, enzyme conjugation, colorization, and reading at 450 nm. The anticancer activity of probiotic bacteria has been demonstrated in in vivo and in vitro systems [13] . The cytotoxicity of L. lactis NK34 was evaluated in various cancer cells and normal cells using the MTT assay and morphology observation (Table 1 and Fig. 1 [14] . However, their proliferation was inhibited by < 45% at the tested concentrations. Lactobacillus acidophilus KFRI342 inhibited 37.9% proliferation of human colon cancer cells, SNU-4 cells [3] . Bacillus polyfermenticus KU3, isolated from kimchi, inhibited 90% proliferation of LoVo, HT-29, AGS, and MCF-7 cells in 10 6 CFU/well treatment [9] . LPS is a major component of the outer membrane of gram-negative bacteria and elicits strong immune responses [1]. In addition, microbial imbalance between gut microbiota with gram-negative bacteria and LPS produced by the latter ones play a key role in the pathogenesis of IBD. The anti-inflammatory activity of L. lactis NK34 was evaluated using LPS as the inflammatory mediator in RAW 264.7 cells (Fig. 2) . Following stimulation with LPS, NO production was reduced in all groups treated with L. lactis NK34 compared with cells not treated with L. lactis NK34. Therefore, we conclude that L. lactis NK34 has no proinflammatory properties, which suggests that it is safe for use in humans. Anti-inflammatory properties of probiotics have been demonstrated in vitro, in animal models, and even in clinical trials. Fig. 3 shows the variation in the values of TNF-α, IL-18, TGF-β2, and COX-2 as inflammatory biomarkers. Treatment with L. lactis NK34 reduced the secretion of pro-inflammatory cytokines TNF-α, IL-18, and COX-2 in LPS-stimulated RAW 264.7 cells (Fig. 3A) . However, anti-inflammatory cytokine TGF-β2 was not influenced noticeable by treatment with L. lactis NK34. Fig. 3B shows the amounts of TNF-α produced in RAW 264.7 cells. Control and L. lactis NK34-treated cells produced 0.869 pg/ml and 0.812 pg/ml of TNF-α, respectively. LPSstimulated and L. lactis NK34-treated LPS-stimulated RAW 264.7 cells produced 52.209 pg/ml and 1.838 pg/ml of TNF-α, respectively (p < 0.01). Inhibition of an inflammatory response by the probiotic strain after stimulation with LPS suggests that L. lactis NK34 interacts with LPS, possibly by preventing interactions of LPS with cells. LPS induced the production of TNF-α, which was reversed by L. lactis NK34. Intestinal bacterial pathogens such as Escherichia coli and Enterococcus faecalis induced the production of the proinflammatory cytokine TNF-α [10] .
In conclusion, probiotic L. lactis NK34 was cytotoxic against SK-MES-1, DLD-1, HT-29, LoVo, and AGS cancer cells, but not normal MRC-5 cells, using MTT assay. The anti-inflammatory effect of L. lactis NK34 was demonstrated by decreases of NO production and pro-inflammatory cytokines. These results suggest that L. lactis NK34 could be used as a probiotic microorganism for its anticancer and anti-inflammatory effects.
